INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 15, 2003 |
VP, Clinical Sciences
Trans History: 37
|
VP, Clinical Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
| Dec 15, 2003 |
VP, Gen Counsel & Secretary
Trans History: 117
|
VP, Gen Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,485 | -- | 12,145 |
| Dec 15, 2003 |
VP, Gen Counsel & Secretary
Trans History: 117
|
VP, Gen Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,692 | -- | 7,692 |
| Dec 15, 2003 |
VP, Gen Counsel & Secretary
Trans History: 117
|
VP, Gen Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 92,308 | -- | 92,308 |
| Dec 15, 2003 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,893 | -- | 11,024 |
| Dec 15, 2003 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- | 5,000 |
| Dec 15, 2003 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
| Dec 15, 2003 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,731 | -- | 10,985 |
| Dec 15, 2003 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,692 | -- | 7,692 |
| Dec 15, 2003 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 42,308 | -- | 42,308 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.